Showing results (51-60 of 191) with videos related to
Sort By:
Pageof 20
The Journal of Cell Biology|May 1, 2013
Stress granules as crucibles of ALS pathogenesisYun R Li, Oliver D King, James Shorter, et al.Proceedings of the National Academy of Sciences of the United States of America|April 25, 2008
A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicityBrian S Johnson, J Michael McCaffery, Susan Lindquist, et al.Acta Neuropathologica|January 29, 2016
Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1Michel Brahic, Luc Bousset, Gregor Bieri, et al.STAR Protocols|January 3, 2022
Live imaging Arabidopsis thaliana embryos under different hydration conditionsYanniv Dorone, Steven Boeynaems, Seung Y RheeBrain Research|March 5, 2018
The epidemiology and genetics of Amyotrophic lateral sclerosis in ChinaXiaolu Liu, Ji He, Fen-Biao Gao, et al.Plos One|March 30, 2012
The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeastAlessandra Chesi, Austin Kilaru, Xiaodong Fang, et al.Analytical and Bioanalytical Chemistry|June 25, 2021
Synthetic hydrogel mimics of the nuclear pore complex for the study of nucleocytoplasmic transport defects in C9orf72 ALS/FTDAlicia K Friedman, Steven Boeynaems, Lane A BakerCell Division|February 9, 2018
Phasing in on the cell cycleSteven Boeynaems, Peter Tompa, Ludo Van Den BoschNature Neuroscience|August 27, 2015
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALSAna Jovičić, Jerome Mertens, Steven Boeynaems, et al.Neuron|September 15, 2020
ALS Genetics: Gains, Losses, and Implications for Future TherapiesGaram Kim, Olivia Gautier, Eduardo Tassoni-Tsuchida, et al.Pageof 20